BRIEF-Aptose Biosciences, CrystalGenomics sign cancer drug deal

Wed Jun 8, 2016 8:18am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

June 8 (Reuters) - Aptose Biosciences Inc

* Co and crystalgenomics says exclusive global option and license agreement focused on development of cg026806 (cg'806) Source text for Eikon: Further company coverage: (Bengaluru Newsroom +1-646-223-8780)